Alcama mediates Edn1 signaling during zebrafish cartilage morphogenesis  by Choudhry, Priya et al.
Developmental Biology 349 (2011) 483–493
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyAlcama mediates Edn1 signaling during zebraﬁsh cartilage morphogenesis
Priya Choudhry a, Deepa Joshi a, Birgit Funke b, Nikolaus Trede a,c,⁎
a Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
b Laboratory for Molecular Medicine (LMM), Harvard Medical School, Cambridge, MA 02139, USA
c Department of Pediatrics, University of Utah, Salt Lake City, UT 84112, USA⁎ Corresponding author. The Huntsman Cancer Insti
Circle of Hope, Salt Lake City, UT 84112, USA. Fax: +1 8
E-mail addresses: priya.choudhry@hci.utah.edu (P. C
nikolaus.trede@hci.utah.edu (N. Trede).
0012-1606/$ – see front matter © 2010 Elsevier Inc. Al
doi:10.1016/j.ydbio.2010.11.006a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 9 September 2010
Revised 1 November 2010
Accepted 3 November 2010
Available online 10 November 2010
Keywords:
Alcama
Edn1
Cartilage
Endoderm
Neural crestThe zebraﬁsh pharyngeal cartilage is derived from the pharyngeal apparatus, a vertebrate-speciﬁc structure
derived from all three germ layers. Developmental aberrations of the pharyngeal apparatus lead to birth
defects such as Treacher-Collins and DiGeorge syndromes. While interactions between endoderm and neural
crest (NC) are known to be important for cartilage formation, the full complement of molecular players
involved and their roles remain to be elucidated. Activated leukocyte cell adhesion molecule a (alcama), a
member of the immunoglobulin (Ig) superfamily, is among the prominent markers of pharyngeal pouch
endoderm, but to date no role has been assigned to this adhesion molecule in the development of the
pharyngeal apparatus. Here we show that alcama plays a crucial, non-autonomous role in pharyngeal
endoderm during zebraﬁsh cartilage morphogenesis. alcama knockdown leads to defects in NC differenti-
ation, without affecting NC speciﬁcation or migration. These defects are reminiscent of the phenotypes
observed when Endothelin 1 (Edn1) signaling, a key regulator of cartilage development is disrupted. Using
gene expression analysis and rescue experiments we show that Alcama functions downstream of Edn1
signaling to regulate NC differentiation and cartilage morphogenesis. In addition, we also identify a role for
neural adhesion molecule 1.1 (nadl1.1), a known interacting partner of Alcama expressed in neural crest, in NC
differentiation. Our data shows that nadl1.1 is required for alcama rescue of NC differentiation in edn1−/−
mutants and that Alcama interacts with Nadl1.1 during chondrogenesis. Collectively our results support a
model by which Alcama on the endoderm interacts with Nadl1.1 on NC to mediate Edn1 signaling and NC
differentiation during chondrogenesis.tute, University of Utah, 2000,
01 581 8547.
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Formation of the pharyngeal apparatus is a crucial part of
vertebrate development because it gives rise to the cartilage,
connective tissue, sensory neurons, thyroid, parathyroid and thymus.
Defects in this process results in human birth defects such as DiGeorge
and Treacher-Collins syndromes. Generation of this tissue is highly
complex, involving extensive cell migration and signaling between
cells derived from all three germ layers. NC cells migrate from the
dorsal neural tube in three distinct streams into a series of pharyngeal
arches and eventually give rise to cartilages and bones of the head.
Each pharyngeal arch is composed of a cylinder of NC surrounding a
mesodermal core. The NC is covered by ectoderm on the outside and
endoderm on the inside. Between the arches, endoderm meets
ectoderm forming the pharyngeal pouches, which later develop into
gill clefts and the epithelial lining of the pharynx, thyroid, parathyroid
and thymus (Graham, 2003).Though NC cells carry intrinsic cues for patterning (Noden, 1983),
they receive extrinsic cues from the surrounding cells and extracellular
matrix as they migrate. Recently, the endoderm has been found to
contribute signiﬁcantly to NC development. Ablation and extirpation
experiments in chicken have revealed that the endoderm carries
patterning information for theNC in segments along the antero-posterior
andmedio-lateral axis (Couly et al., 2002; Ruhin et al., 2003). In addition,
genetic mutants in zebraﬁsh have also revealed the requirement of
endoderm in formation of cartilage. The sox32-deﬁcient casanovamutant
lacks endodermal pouches and cartilages that are rescued by wild-type
endodermal transplants (David et al., 2002). Likewise, the tbx1-deﬁcient
van goghmutant fails to form segmented endodermal pouches resulting
in fusion of the pharyngeal cartilages (Piotrowski and Nusslein-Volhard,
2000). Similarly, the zebraﬁsh mutant for integrinα5 lacks the ﬁrst
endodermal pouch and the anterior part of the hyoid cartilage (Crump
et al., 2004). Although these data demonstrate that endoderm is essential
for cartilage development, the cellular and molecular interactions
between the NC and endodermal cells are not fully understood.
One major signaling factor that provides an extrinsic cue
regulating NC differentiation is endothelin-1 (edn1). edn1 is expressed
in the mesodermal cores, ectoderm and endoderm of the pharyngeal
arches, but not in NC. Edn1 signals the NC and induces ventralization
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Edn1 cleaving enzymes and other genes in the Edn1 signaling cascade
(sucker, schmerle, hoover and sturgeon) cause similar cartilage defects,
and have been placed in the same class (Kimmel et al., 2001;
Piotrowski et al., 1996). Typically, the ventral domains of the ﬁrst two
arches are reduced in size, changed in orientation, and fused with the
dorsal domains, while the posterior arches are mostly unaffected.
Hence, Edn1 is an important signaling factor that is required non-
autonomously for NC differentiation into cartilage.
Other molecular players that may signal from endoderm to NC
remain elusive. While Alcama is commonly used as a marker for
pharyngeal endoderm in zebraﬁsh (Crump et al., 2004; Piotrowski and
Nusslein-Volhard, 2000), its role in this tissue has not been elucidated
thus far. In zebraﬁsh, Alcama has been studied primarily for its role in
neurogenesis (Diekmann and Stuermer, 2009; Fashena and
Westerﬁeld, 1999). Initially identiﬁed in chicken for its role in neurite
extension (Burns et al., 1991), ALCAMA has now been shown to be
involved in axonal pathﬁnding and axonal fasciculation (Diekmann
and Stuermer, 2009; Weiner et al., 2004). Its non-neuronal roles
include T-cell activation (Bowen et al., 2000; Fashena and Westerﬁeld,
1999; Ofori-Acquah and King, 2008; Zimmerman et al., 2006),
metastasis (Degen et al., 1998; Ofori-Acquah and King, 2008) and
cell migration (Heffron and Golden, 2000). Human ALCAM is a
transmembrane glycoprotein having ﬁve Ig domains, a transmembrane
domain and a short cytoplasmic tail. It mediates cell-cell clustering
through homophilic (ALCAM-ALCAM) as well as heterophilic
(ALCAM-NgCAM and ALCAM-CD6) interactions (DeBernardo and
Chang, 1996; Degen et al., 1998). While ALCAM can activate signal
transduction pathways in neighbouring cells through heterophilic
interactions (Ibanez et al., 2006), a non-autonomous role of ALCAM has
not been deﬁned thus far. In this paper we demonstrate that zebraﬁsh
Alcama, expressed in the pharyngeal endoderm, is an important
non-autonomous molecule for NC differentiation. In addition, we
provide evidence that Alcama mediates Edn1 signaling from the
endoderm to the NC by interacting with Nadl1.1 (NgCAM in chicken)
on the NC cells. These data for the ﬁrst time link Alcama to Edn1
signaling and identify a role for the molecular interaction between
Alcama and Nadl1.1 in cartilage formation.
Materials and methods
Fish stocks and maintenance
Fish were maintained at 28.5 °C under standard conditions
(Westerﬁeld, 2000) and were staged as described (Kimmel et al.,
1995). The suckertf216b mutant (edn1−/−) line was obtained from
Zebraﬁsh International Resource Center (Miller et al., 2000). Homo-
zygous mutants were obtained by inbreeding of heterozygous
carriers. Tg(ﬂi1:EGFP) ﬁsh have been previously described (Lawson
andWeinstein, 2002). Alcian Blue stained larvae of furina−/−mutants
at 5 days post fertilization (dpf) were a kind gift from Chuck Kimmel
(Institute of Neuroscience, University of Oregon).
Identiﬁcation and genotyping of edn1−/− mutants
edn1−/− mutants have an A-to-T missense mutation (Miller et al.,
2000). The mutants were identiﬁed by Derived Cleaved Ampliﬁed
Polymorphic Sequences assay (Neff et al., 1998). DNA was extracted
from the tails of stained embryos and PCR was conducted using the
primers 5'-AGATGCTCCTGCGCAAGTTTTCTAG-3' and 5'-CTGACT-
TACTCTGGTGTGTTCACCC-3'. The mismatch in the primer which
introduces a XbaI site in the wild-type (WT) but not in the mutant
is underlined. The 93 bp PCR product, when digested with XbaI, gives
a 68 bp product in WT. The 93 and 68 bp products were resolved on a
4% Metaphor agarose gel (Lonza). All the identiﬁed WT and mutants
were included in the analysis.Cloning and RNA transcription
RNA extracted from48 h post fertilization (hpf) Tü larvaewas used
for cDNA synthesis. PCR for alcama was performed using the forward
primer 5'-ggatccgccaccATGCATTCGGTTATCTGCCTTTTCG-3' with a
BamHI and Kozak overhang and the reverse primer 5'-ctcgagTTAGA-
CATCTGCTTTATGATTGTTCTCCTCC-3' with a XhoI overhang. The over-
hangs are shown in lower case. The PCR product was cloned into
pCMV-Script using TOPO TA kit (Invitrogen). The edn1 cDNA clone in
pBK-CMV was obtained from ZIRC.
To make sense RNA for injection, the edn1 and alcama plasmids
were cut with KpnI and in vitro transcription was driven from the T3
promoter using mMessage Machine kit (Ambion). ednrb1 was cloned
from cDNA into TOPO TA using the primers 5'-ATGCGTTTCCAAAT-
TATTATGGAAACAAGATGCG-3' (forward) and 5'-TCAGTGCCTAATTT-
GAAGTATACTTGTTGGAGAC-3' (reverse) and this plasmid was used to
make ISH probe.
Morpholino anti-sense oligonucleotide and RNA injections
Translation blocking (TB) and splice site blocking (SB) Morpho-
linos (MOs) were designed to bind 143 bp upstream of the
transcription start site and at the donor site of exon 6 alcama
mRNA, respectively. alcama blocking and control MO were purchased
from Gene Tools, Inc. The sequences are TB MO: 5'-GTTCTCCTTTATA-
CAGTCCGGCGAC-3'; SB MO: 5'-GCAGTCCCTCACCTTAATGTTAAAG-3';
control MO: 5'-TGATCACCTGCAGATGGACGCTGCG-3'. The optimal
doses were determined to be 1.1 ng for the TB MO and 2.2 ng for
the SB MO. The control MO was injected at 1.1 ng per embryo. The TB
MO for nadl1.1: 5-'CAGGCTGACTCTGCACTGGAGGCAT-3' has been
previously described (Wolman et al., 2007) and was injected at 4.4 ng
per embryo. 26 pg of alcama or edn1 RNA was injected per embryo.
MOs and RNA were dissolved in molecular biology grade water and
pressure injected into one to four cell zebraﬁsh embryos. For
suboptimal doses, the alcama TB MO was used at 0.5 ng and the
nadl MO at 1.1 ng per embryo.
Treatment with proteasome inhibitor MG-132
MG-132 was dissolved in DMSO at a stock concentration of
500 mM. Embryos were dechorionated at 5 hpf and transferred to E2
with 50 μM MG-132 (Bretaud et al., 2007) or with 1% dimethyl
sulfoxide (DMSO). MG-132- and DMSO-treated control larvae were
ﬁxed at 30 hpf and stained.
Tissue labeling procedures
Alcian Blue cartilage staining and dissection were performed as
described (Kimmel et al., 1998). Whole mount RNA in situ
hybridization (ISH) with digoxigenin was performed as described
(Miller et al., 2000). The plasmids for dlx2a, dlx3b, dlx5a were a kind
gift from Gage DeKoeyer Crump (Keck School of Medicine, University
of Southern California). The plasmid for nadl1.1 was a gift fromGavin J
Wright (Cell Surface Signalling Laboratory, Wellcome Trust Sanger
Institute). Alcama protein was stained using Zn-5 antibody from ZIRC
at 1:500 dilution. A goat anti-mouse secondary antibody conjugated
with Alexa 555 (Invitrogen) was used for ﬂuorescence quantiﬁcation
purposes. DAPI staining was used for counting the number of cells in
the pouches.
Imaging and quantiﬁcation
Skeletons and ISH embryos were photographed on a Nikon Y-IDP
microscope at 20× zoom using Spot software. Confocal images of
antibody stained embryos were taken on Olympus FV1000 micro-
scope. Images of all larvae from the same experiment were taken
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using Imaris software and ﬂuorescence intensity of each z-sectionwas
measured using ImageJ. For immunohistochemistry coupled to ISH,
the secondary antibody conjugated to alkaline phosphatase (Bio-Rad)
was used with Fast Red for detection (Sigma-Aldrich). Fluorescent
ISH was performed following immunohistochemistry as described
(Welten et al., 2006).
Results
alcama is necessary for ventral cartilage formation
We tested whether alcama plays a role in cartilage morphogenesis
by injection of two different MOs: one blocking translation (TB MO),
and the other blocking splicing of exon 6 (SB MO; Fig. 1A). Staining
with Zn-5 antibody, which recognizes Alcama, revealed effective
knockdown of Alcama protein by both MOs (Fig. 1C–E). 5 dpf alcama
morphants are characterized by a protruding lower jaw, cardiacFig. 1. alcama morphants have defects in facial skeletal patterning. (A) Graphic representat
48 hpf WT larva with the box indicating the region shown in (C)–(E). 48 hpf control (C),
effectively knock down alcama expression in the heart (arrowheads) and pouches (arrows
morphants have a protruding jaw (arrows), cardiac edema (arrowheads) and an absent sw
(I) morphants at 5 dpf. The line indicates the length of the pharyngeal cartilage, which is
ventrally in alcama morphants. Scale bars: 50 μm.edema and absence of swim bladder (Fig. 1G). The jaw is shorter in
the antero-posterior (A-P) direction and the ventral elements of the
anterior arches, Meckels (mc) and ceratohyal (ch), are bent ventrally
leading to the protruding lower jaw (Fig. 1I). Injection of the TB MO
consistently leads to a more pronounced phenotype than the SB MO.
Therefore, in subsequent experiments we use the TB MO exclusively
and refer to it as alcama MO.
To eliminate the possibility that the jaw defect is caused by non-
speciﬁc MO-induced p53-activation (Robu et al., 2007), alcamaMO was
injected into the p53 (I166T)mutant line (Parant et al., 2010). Alcian blue
staining of 5 dpf larvae revealed that the percentage of individuals with
affected cartilage was equivalent in wild-type (WT) and the p53−/−
mutant lines (Fig. S1). The speciﬁcity of thephenotypewas also tested by
co-injection of alcama MO and alcama RNA. alcama RNA can rescue the
ventral cartilage defect caused by alcama knockdown (Fig. S1). This
indicates that the cartilagedefect is causedby alcamaknockdownandnot
by off-target MO effects and that alcama is required for the proper
formation of anterior ventral cartilages in zebraﬁsh.ion of alcama RNA illustrating the position of TB and SB MOs. (B) Nomarski image of a
alcama TB (D), and alcama SB (E) morphants stained with Zn-5 antibody. Both MOs
). (F, G) Lateral views of 5 dpf larvae injected with control and alcama TB MOs. alcama
im bladder (open arrows). Lateral views of Alcian blue-stained control (H) and alcama
shortened in alcama morphants. The arrow points to Meckels cartilage, which is bent
486 P. Choudhry et al. / Developmental Biology 349 (2011) 483–493Cartilage defects in alcama morphants are reminiscent of the edn1-class
of mutants
In alcama morphants the pharyngeal skeleton is shorter in the
antero-posterior direction and the anterior arch ventral cartilages (mc
and ch) point ventrally rather than anteriorly (Fig. 1H, I). In addition,mc
and ch are fused to their respective dorsal elements, palatoquadrate
(pq) and hyosymplectic (hm) (Fig. 2A, C). The posterior arches are
shorter in the antero-posterior direction, but are otherwise unaffected
(Fig. 1I). To identify the pathway affected in alcama morphants, we
compared the jaw phenotype in alcama morphants to previously
described cartilage mutants. The three characteristic phenotypes of the
ventral cartilages in alcama morphants; shortening, change of orienta-
tion and fusion to dorsal cartilages, are typical of the edn1-class of
mutants (Piotrowski et al., 1996;Walker et al., 2006, 2007). Particularly
striking is the similarity of alcama morphants to furinA−/− mutants
(Fig. 2C, E). This observation suggests that alcama and edn1 may be in
the same genetic pathway.
edn1 regulates alcama protein levels in the pharyngeal pouches
In order to test if an epistatic relationship exists between alcama
and edn1, we analyzed edn1 expression in alcama morphants. While
alcama is also expressed in the heart, retina and the brain (Fig. S2A),Fig. 2. alcamamorphants have cartilage defects similar to the edn1 class of mutants. Flatmou
corresponding schematics (B, D, F, H). The joint between Meckel's and palatoquadrate is fus
absent in alcama morphants and furinA−/− mutants leading to a fusion of the ceratohyal an
Meckel's cartilage and ceratohyal, but edn1−/− mutants have the most severe defect with
indicated with arrows in A and B. Fusions at joints are indicated with asterisks in (C)–(H)
(hyomandibula), ch (ceratohyal), sy (symplectic), and ih (interhyal). Scale bar: 50 μm.expression of edn1 and alcama coincides in the ventral pharyngeal
area from 18 to 36 hpf (Thisse and Thisse, 2004, 2005). By 30 hpf edn1
expression is clearly demarcated in the mesodermal cores and surface
ectoderm of pharyngeal arches in addition to the pharyngeal pouches
(Miller et al., 2000). At that stage, alcama is expressed in pharyngeal
pouch endoderm (Kopinke et al., 2006). edn1 expression is unchanged
between control and alcamamorphants, suggesting that edn1may act
upstream of alcama (Fig. 3A, B).
To test this possibility, we analyzed Alcama protein expression in
pharyngeal pouches of edn1−/− mutants. 30 hpf larvae were co-
stained with Zn-5 Alcama antibody and DAPI (Fig. 3C, D). Confocal
images were cropped to individual endodermal pouches and
analyzed. Alcama intensity in individual pouches of edn1−/−mutants
was down-regulated to less than 40% of the WT individuals (Fig. 3E).
The total number of Alcama-expressing cells in each pouch (deter-
mined by DAPI staining) is comparable between WT and edn1−/−
mutants (Fig. 3F), indicating that endodermal pouch tissue is present
in edn1−/−mutants, but it expresses reduced amounts of Alcama. This
observation suggests that edn1 possibly regulates Alcama levels in
pharyngeal pouches.
Edn1 is produced as a proprotein, which is cleaved twice to
produce a diffusible 21-amino acid peptide. The peptide acts by
binding to endothelin receptors (Ednr) coupled to G proteins. In
zebraﬁsh, two Ednrs exist; EdnrA and EdnrB. Previous ISH studiesnts of mandibular and hyoid cartilage from 5 dpf Alcian Blue-stained larvae (A, C, E, G);
ed in alcamamorphants and furinA−/− and edn1−/−mutants. Similarly, the interhyal is
d hyosymplectic cartilages. alcama morphants and furinA−/− mutants have misshapen
a lack of ceratohyal and severely misshapen Meckel's cartilage. DV joint regions are
. Cartilages are labeled as followed: pq (palatoquadrate), mc (Meckel's cartilage), hm
Fig. 3. Edn1 regulates Alcama levels. edn1 is expressed in the mesodermal cores (arrowheads) of the ﬁrst three arches and in pharyngeal pouches 2–4 (dotted lines) (A). Its expression is
unchanged inalcamamorphants (B). Cropped image of a singlepharyngeal pouch from30 hpfWT sibling (C) and edn1−/−mutant (D) stainedwith Zn-5 (anti-Alcama) antibody in red and
DAPI in blue. (E) Bar graph showing the difference in total Alcama protein in a pouch (second or third pouch), represented as measured ﬂuorescence intensity normalized to WT;
*p-valueb0.0001bya two-tailed t-test. The bar graph in (F) shows the total numberof cells per pouch isunchanged inWTand edn1−/−mutants; **p-value=0.08495bya two-tailed t-test.
n=14 forWT; n=11 for edn1−/−mutants for this experiment whichwas repeatedwith similar results. (G) edn1 regulates the Alcama levels in pouches. The bar graph shows the sum of
Alcama intensity in the ﬁrst three pouches of 30 hpf edn1−/− (green) andWT (red) larvae after the indicated injections (p-valueb0.0001 by one-way analysis of variance). (H) Bar graph
showing the sum of Alcama intensity in the ﬁrst three pouches of 30 hpf edn1−/− larvae after treatment with DMSO or the proteasome inhibitor MG-132; ***p-value=0.0009 by a two-
tailed t-test. N is the number of larvae in a single experiment, which was repeated with similar results. a1 and a2 label pharyngeal arches 1 and 2. Scale bars: 50 μm.
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exclusively in the NC of pharyngeal arches (Nair et al., 2007). We
cloned ednrb1 and validated that this receptor is expressed diffusely
throughout the endoderm and NC (Fig. S2B). ednrb1 expression in the
endoderm is compatible with our hypothesis that Edn1 signals to the
endoderm to regulate Alcam levels.
To corroborate our hypothesis that edn1 regulates Alcama levels,
we tested whether edn1 over-expression could rescue Alcama levels
in edn1−/−mutants. edn1 RNA was injected into edn1−/− embryos at
the 1-cell stage and Alcama protein levels were quantiﬁed at 30 hpf as
discussed previously with one modiﬁcation. The ﬂuorescence inten-
sity of Zn-5 staining in the pharyngeal area from the ﬁrst to the thirdpouch, instead of single pouches, was measured and normalized to
uninjected WT (Fig. S3). alcama RNA was injected as a positive
control. edn1 RNA injection results in more than 50% increase in
Alcama protein in WT and edn1−/−mutants (Fig. 3G), suggesting that
edn1 regulates Alcama levels in the endoderm.
Additionally, we investigated the mechanism by which Edn1
regulates Alcama. ISH studies revealed that alcama RNA levels, while
slightly down-regulated in edn1−/− mutants (Fig. S2C, D), do not
explain the severe down-regulation observed in Alcama protein levels
(Fig. 3D, E). This observation suggests that edn1 does not regulate
Alcama levels via regulating transcription. Previous studies have
indicated that edn1 may lead to Snail and β-catenin protein
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2005; Sato-Jin et al., 2008). To test whether Edn1 stabilizes Alcama
protein by interfering with its degradation by the proteasome, we
treated edn1−/− larvae with the proteasome inhibitor MG132 and
measured Alcama levels. The ﬂuorescence intensity was normalized
to DMSO-treated edn1−/− mutants. Alcama levels in the pharyngeal
pouches increased by more than 300% upon treatment with MG-132
(Fig. 3H), indicating that inhibition of proteasomal degradation is
involved in Edn1-induced regulation of Alcama. While edn1 RNA
injection increases Alcama levels in the pharyngeal pouches, Alcama
levels are unchanged in the heart and retina, where Edn1 signaling is
not active (data not shown). These experiments indicate that Edn1
stabilizes Alcama levels speciﬁcally in the pharyngeal endodermal
pouches by inhibiting some component of the proteasome pathway.
alcama is required for edn1-dependent differentiation of NC
We have determined that alcama morphants have defects in
ventral cartilages. Since cartilage is formed from NC in the pharyngeal
arches, we investigated whether alcama knockdown caused a defect
in the patterning or speciﬁcation of NC. We injected alcama MO into
Tg(ﬂi:EGFP) line which labels NC cells. Analysis of larvae at 30 hpf, a
stage at which the cranial NC has already populated the arches,
revealed that NC migration is unaffected in alcama morphants (Fig.
S4B). This observation was corroborated by ISH with the NC marker
distalless 2a (dlx2a) at the same developmental stage, showing normal
patterning of NC (Fig. S4D). In addition nkx2.3 expression in
endoderm (Fig. S4F), and edn1 expression in mesodermal cores and
endodermal pouches (Fig. 3B) is unaffected in alcama morphants,
suggesting that NC, endoderm and mesoderm are all patterned and
speciﬁed correctly in the pharyngeal region of alcamamorphants. This
result implies that similarly to genes in the Edn1 pathway, Alcama is
not required for NC migration or speciﬁcation, but is involved in a
later stage of cartilage morphogenesis.
Our data suggest that Alcama functions downstream of Edn1 in
cartilage formation. To assess the functional importance of alcama in
the Edn1 signaling pathway, we analyzed the expression of genes
downstream of edn1 in alcamamorphants. Edn1 signaling is required
for the expression of Dlx and Hand2 transcription factors in NC (Miller
et al., 2000; Walker et al., 2006). Like Edn1, Hand2 is required for
ventral cartilage formation and Dlx factors pattern the dorso-ventral
axis of pharyngeal arches (Depew et al., 2002; Miller et al., 2003). In
alcama morphants, the expression of hand2, dlx3b, dlx5a and dlx6a is
strongly reduced in the ﬁrst and the posterior arches, and mildly
reduced in the second arch at 30 hpf (Fig. 4B, E, H, K). Although hand2
expression recovers by 48 hpf, dlx genes continue to be down-
regulated (Fig. S5). At 30 hpf, hand2 expression is down-regulated in
NC, but unaffected in the heart of alcama morphants (Fig. 4B) and
edn1−/− mutants (Fig. 4C), indicating that Alcama is required
speciﬁcally for edn1-dependent expression of NC genes.
edn1-dependent bapx1 expression in the intermediate region of
the precartilage arch is required for cartilage joint formation (Miller et
al., 2003). Consistent with the joint fusion observed in alcama
morphants, bapx1 expression in the intermediate region of arch1 is
down-regulated in alcama morphants (Fig. 4N). Down-regulation of
Edn1-dependent genes in alcama morphants is similar to, but less
severe than that observed in edn1 mutants (Fig. 4C, F, I, L, O). This
observation is consistent with the less severe jaw defect observed in
alcama morphants when compared to edn1 mutants. Taken together
these data suggest that Alcama is required for Edn1-dependent NC
differentiation and the proper formation of ventral cartilage and jaw
joint.
Our data suggests that NC is patterned and speciﬁed correctly in
alcamamorphants (Fig. S3). Hence, the failure of NC to express edn1-
dependent genes that come on later in development, suggests that
alcama knockdown causes a defect in NC differentiation. In subse-quent experiments, dlx5a expression is used as a marker for NC
differentiation due to its robust expression. The speciﬁcity of MO-
induced NC differentiation defect was tested by co-injection of alcama
MOwith alcama RNA, and by alcamaMO injection in p53−/−mutants
(Robu et al., 2007). dlx5a expression was categorized as strong (all
arches stained), partial (all arches stained but weaker) and absent
(most arches missing staining and some with very weak staining)
(Fig. S6A–C). Co-injection of alcama RNA with alcama MO decreases
the number of affected individuals (absent dlx5a staining) to WT
levels (Fig. S6D), suggesting that the NC differentiation defect is
caused speciﬁcally by alcama knockdown. The percentage of affected
larvae is similar in WT and p53−/−mutants (Fig. S6D), indicating that
similar to the cartilage defect, the NC differentiation defect is caused
by alcama knockdown and is not dependent on off-target MO effects.
alcama over-expression can rescue NC differentiation defect in edn1−/−
mutants
Our data suggests that edn1 regulates Alcama levels and
knockdown of either gene results in a NC differentiation defect. We
tested our hypothesis that edn1 affects NC differentiation via Alcama,
by over-expressing alcama in edn1−/−mutants followed by analysis of
NC differentiation. We injected alcama RNA into edn1−/− mutants at
the one-cell stage and assessed dlx5a expression at 30 hpf as a marker
for NC differentiation. dlx5a staining was classiﬁed as absent, partial
and strong (Fig. 5A–C) and the number of larvae in each categorywere
counted. edn1 over-expression was used as a positive control,
resulting in a 300% increase in the number of edn1−/− mutants with
dlx5a staining (sum of strong and partial) (Fig. 5D). alcama RNA
induces similar increases of rescued edn1−/− mutants as edn1 RNA,
although full rescue of dlx5a expression was not achieved. This
indicates that Alcama functions downstream of Edn1 to regulate NC
differentiation. To bolster this hypothesis, we asked if edn1 rescue of
edn1−/− mutants could be abrogated by alcama knockdown. Indeed,
co-injection of alcamaMO abrogates the ability of edn1 RNA to rescue
dlx5a staining in edn1−/− mutants (Fig. 5D), supporting our previous
ﬁnding that alcama expression is necessary for Edn1 function.
Injection of either edn1 or alcama RNA was unable to rescue the
cartilage defect of edn mutants at 5 dpf, possibly due to dilution of
RNA in rapidly dividing cells.
As opposed to edn1−/− mutants, less than 5% of WT larvae have
absent dlx5a expression. alcama or edn1 RNA injections into WT
embryos do not affect dlx5a expression (Fig. 5E), demonstrating that
these genes do not negatively affect NC differentiation when they are
over-expressed. Co-injection of edn1 RNAwith alcamaMO results in a
similar percentage of larvae with absent dlx5a staining to that
observed in alcama morphants (Fig. 5E). However, there are more
larvae with strong dlx5a expression, suggesting that edn1 may
regulate NC differentiation by another parallel pathway independent
of alcama. In aggregate, these data provide evidence that Alcama
functions downstream of Edn1 in regulation of NC differentiation.
Nadl1.1 mediates Alcama differentiation signal to the NC
Since Alcama is expressed in the endoderm, we investigated the
possibility that it interacts with another protein to mediate Edn1-
signaling to the adjacent NC. Nadl1 (Ng-CAM in chick) has been
shown to interact with Alcama in the chick brain to promote neurite
extension (DeBernardo and Chang, 1996). Zebraﬁsh have two
orthologs of Ng-CAM, nadl1.1 and nadl1.2, but only nadl1.1 is
expressed in the NC (Figs. 6A and 7A). To test if nadl1.1 is involved
in cartilage development, we used a previously described TB MO
targeting nadl1.1 (Wolman et al., 2007). Phenotypically, nadl1.1
morphants are similar to alcama morphants: by 5 dpf they have a
protruding lower jaw, cardiac edema and absent swim bladder (data
not shown). Similar to alcamaMO, nadl1.1MO affects edn1-dependent
Fig. 4. alcama is required for edn1-dependent gene expression. Ventral views of larvae at 30 hpf (A–C), and lateral views at 30 hpf (D–L) and at 48 hpf (M–O) respectively. ISH for
hand2 (A–C), dlx3b (D–F), dlx5a (G–I), dlx6a (J–L), and bapx1 (M–O) in control and alcamamorphants and in edn1−/−mutants. hand2, dlx3b, dlx5a and dlx6a expression is strongly
reduced in the ﬁrst and branchial arches and moderately reduced in the second arch in alcamamorphants. Their expression is strongly reduced in all arches in the edn1−/−mutants.
bapx1 expression in the ﬁrst arch intermediate domain is moderately reduced in alcama morphants and strongly reduced in edn1−/−mutants. a1 and a2 label pharyngeal arches 1
and 2. Dotted lines highlight pharyngeal pouches 1 and 2. Scale bars: 50 μm.
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the arches with a more pronounced effect on the posterior arches
(Fig. 6B–E). Alcian blue staining reveals cartilage defects reminiscent
of alcama morphants: mc and ch are changed in orientation and are
fused to pq and hm, respectively (Fig. 6G–H'). Injection of nadl1.1MO
into p53−/− mutants yields similar percentages of larvae with dlx5a
down-regulation and jaw abnormalities (Fig. 6F, I), indicating that the
observed effect is speciﬁc to nadl1.1 knockdown. These data suggestthat nadl1.1may be another player in the Edn1 signaling pathway that
regulates ventral cartilage formation.
We investigated the possibility that nadl1.1 is another downstream
effector of Edn1-mediated NC differentiation and cartilage morpho-
genesis that functions independently of Alcama. nadl1.1 expression is
not down-regulated in edn1−/−mutants as compared to WT at 30 hpf
(Fig. S2E, F), indicating that edn1 does not regulate nadl1.1 at the
transcriptional level. Hence, it is unlikely that nadl1.1 functions in the
Fig. 5. alcama rescues NC differentiation defect in edn1−/− mutants. Lateral views of 30 hpf larvae with representative absent (A), partial (B) or strong (C) staining for dlx5a. Bar
graphs show the percentage dlx5a expressing larvae in edn1−/−mutants (D) and WT (E) following the stated injections. edn1 or alcama RNA was injected with or without alcama
MO. alcama RNA decreases the percentage of affected individuals (absent dlx5a staining) by nearly 30% in edn1−/−mutants and co-injection of alcamMo abrogates the ability of edn1
RNA to rescue dlx5a expression in edn1−/−mutants. Indicated p-values are calculated by Fishers exact test. n depicts the number of experiments and N depicts the total number of
larvae represented in the columns of the plot (p-valueb0.0001 for both D and E byχ2 analysis). a1 and a2 label pharyngeal arches 1 and 2. Dotted lines highlight pharyngeal pouches
1 and 2. Scale bar: 50 μm.
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alcama and nadl1.1 causes very similar defects in cartilage morpho-
genesis and NC differentiation, supporting our hypothesis that the
two adhesion molecules might interact.
alcama and nadl1.1 are expressed adjacent to each other in the
endoderm and NC respectively (Fig. 7A), supporting our hypothesis
that Nadl1.1 may propagate Alcama differentiation signal from the
endoderm to NC. To bolster this hypothesis, we ﬁrst asked if alcama-
mediated rescue of dlx5a expression in edn1−/− mutants (Fig. 5) is
abrogated by nadl1.1 knockdown. Co-injection of nadl1.1 MO with
alcama RNA indeed blocked rescue of dlx5a expression in edn1−/−
mutants (Fig. 7B), suggesting that Nadl1.1 expression is necessary for
transmission of Edn1 signal through Alcama to NC.
To corroborate this observationwe next tested possible interaction
of Alcama and Nadl1.1 in synergy experiments by co-injecting
suboptimal doses of alcama MO and nadl1.1 MO into WT embryos.
The read-out consisted of assessment of NC differentiation (dlx5a
expression) and cartilage morphogenesis. While suboptimal doses of
alcama and nadl1.1 MOs alone do not cause signiﬁcant changes in
dlx5a expression or cartilage shape, co-injection resulted in synergis-
tic increase in the number of larvae with down-regulated dlx5a
expression and cartilage defects (Fig. 7C, D). This indicates that
Alcama and Nadl1.1 interact during cartilage morphogenesis. Taken
together with the ability of nadl1.1 MO to block rescue of NC
differentiation by Alcama over-expression in edn1−/− mutants, these
data suggest that Alcama affects cartilage and NC differentiation by
interacting with Nadl1.1.Discussion
Our data shows for the ﬁrst time that endodermally expressed
Alcama is required for differentiation of NC and ventral pharyngeal
cartilagemorphogenesis. The alcama-deﬁcient cartilage defect resem-
bles that seen in edn1-class of mutants. In addition, edn1 regulates
Alcama protein levels in the pharyngeal endoderm. Moreover, similar
to genes involved in Edn1 signaling, alcama is dispensible for NC
patterning and migration, but is required for NC differentiation.
Additionally, alcama over-expression partially rescues the NC differ-
entiation defect in edn1−/−mutants, indicating that Alcama mediates
Edn1 signaling to NC. Finally, we identify that Nadl1.1, an interacting
partner of Alcama, is crucial for transmitting Alcama differentiation
signal to NC and promoting ventral cartilage morphogenesis. These
data lead us to propose amodel (Fig. 8), whereby Edn1 signaling turns
on dlx genes in the NC by two independent pathways. Edn1 binds to
its receptor on NC to activate NC genes directly. In parallel, Edn1 binds
to its receptor on the endoderm to stabilize Alcama protein, which in
turn binds to Nadl1.1 on NC and further activates NC genes. Activation
of both pathways is required for normal differentiation of NC and
cartilage morphogenesis.
edn1 signals to NC by two parallel pathways
Edn1 is synthesized as a proprotein, which is cleaved twice by
Furin and endothelin-converting enzyme resulting in a short, active
Edn1 peptide. This short, active Edn1 peptide binds to the G protein-
Fig. 6. nadl1.1morphants phenocopy alcamamorphant cartilage defects. Dorsal views (A–C) and lateral views (D, E) of 30 hpf larvae. nadl1.1 is expressed in the pharyngeal arches,
diencephalon, telencephalon, hindbrain neurons, neural tube and pectoral ﬁn in 30 hpf WT larvae (A). 30 hpf nadl 1.1 morphants have down-regulated hand2 (C) and dlx5a
(E) expression as compared to uninjected WT (B, D). (F) Bar graph showing that the percentage of larvae with down-regulated (absent) dlx5a expression remains unchanged in the
p53−/− background (p-value=1.000 by Fishers exact test, indicating that WT and p53−/−mutants are not signiﬁcantly different). Dissected mandibular and hyoid elements from
5 dpf WT and nadl1.1 morphant larvae stained with Alcian blue (G, H) and their corresponding schematics (G', H'). The joint fusions in nadl1.1 morphants (H, H')
marked by * resemble those seen in alcamamorphants. (I) Bar graph comparing the percentage of larvae with affected cartilage in alcamamorphants in WT versus p53−/−mutants
(p-value=0.1941 by Fishers exact test, indicating that WT and p53−/−mutants are not signiﬁcantly different). N is the total number of larvae from three experiments. Scale bars:
50 μm.
491P. Choudhry et al. / Developmental Biology 349 (2011) 483–493coupled Edn1 receptor. Phospholipase C enzyme further transmits the
signal by producing inositol trisphosphate and diacylglycerol. Mouse
mutants for Edn1, Ednra and the G-protein share skeletal defects with
zebraﬁsh mutants for edn1, furinA and phospholipase C beta 3 (plcβ3);
the ventral domains of the lower jaw are reduced in size and fused to
the dorsal domains in both species (Clouthier et al., 1998, 2000;
Dettlaff-Swiercz et al., 2005; Kurihara et al., 1994; Miller et al., 2000;
Walker et al., 2006, 2007). Thus Edn1 signaling has been conserved
during evolution to regulate ventral cartilage morphology.
Zebraﬁsh edn1−/− and plcβ3−/−mutants have more severe ventral
cartilage reductions and joint fusions than alcama morphants. The
milder cartilage defect in alcama morphants correlates with the less
pronounced reduction of dlx, hand2 and bapx1 gene expression in NC.
We propose that this milder defect is due to two concomitant, additive
pathways for edn1 signaling; the ﬁrst acts directly in the NC through the
Edn1 receptor and the second activates Alcama signaling from the
endoderm to the NC (Fig. 8). While both pathways are affected in edn1
and plcβ3mutants, in alcamamorphants direct signaling from the Edn1
receptor is still intact and can partially activate dlx gene expression in
the NC, resulting in a milder phenotype.Edn1 regulates alcama protein levels in pharyngeal endoderm
Previous data has implicated Edn1 as a regulator of the proteasome
pathway (Rosano et al., 2005; Sato-Jin et al., 2008). Our data suggest
that edn1 stabilizes Alcama protein by inhibiting the proteasome
pathway because inhibiting the proteasome pathway in edn1−/−
mutants results in increased Alcama levels. It is still unknown
whether Edn1 stabilizes Alcama by inducing a structural change
that prevents polyubiquitination, or indirectly by regulating tran-
scription of proteasome subunits or by activation of de-ubiquitinases.
Alternatively, Alcama may not be a direct target of the proteasome
pathway; instead a chaperone protein that stabilizes Alcamamight be
the target of proteasome pathway. An alternative possibility is that
Edn1 signals to NC and thus induces Alcama stabilization indirectly.
Further investigation into this mechanism will broaden our under-
standing of the process of NC differentiation.
Further inquiry is also needed into other proteins/signals regulat-
ing alcama expression. Although edn1 RNA injections and MG132
treatment led to higher Alcama expression, in both cases expression
was mostly restricted to the endoderm and not the NC. This data
Fig. 7. alcama and nadl1.1 interact during cartilage formation. (A) Lateral view of a 30 hpf WT larva stained with Zn-5 antibody (Fast Red) and anti-sense nadl1.1 RNA (Fluorescein),
revealing that nadl1.1 is expressed in the NC adjacent to alcama in the endoderm. The bar graphs display the percentage of 30 hpf edn1−/− (B) andWT (C) larvae with dlx5a staining
after the indicated injections. (B) shows that nadl1.1 is required for alcama rescue of dlx5a expression in edn1−/−mutants (p-valueb0.0001 by Fishers exact test). (C) and (D) show
that alcama and nadl1.1 interact during dlx5a expression and cartilage morphogenesis. (D) Bar graph displaying the percentage of 5 dpf larvae with affected cartilage after the
indicated injections (p-valueb0.0001 by χ2 analysis). n indicates the number of experiments and N the total number of larvae. Scale bar: 50 μm.
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Fig. 8.Model demonstrating howAlcamamediates Edn1 signaling and NC differentiation.
Previous data has supported the model that Edn1 peptide binds to its G-protein-coupled
receptor on NC to turn on transcription of NC genes. We propose a parallel pathway by
which Edn1 signaling stabilizes Alcama protein in endodermal cells. Alcama, in turn, binds
to Nadl1.1 in NC and regulates NC differentiation.
492 P. Choudhry et al. / Developmental Biology 349 (2011) 483–493points to an endoderm-speciﬁc role of Alcama in cartilage formation.
Similarly, edn1 and alcama RNA injections into the one-cell stage
induced rescue of dlx5a expression, speciﬁcally in NC. Further
investigation of these mechanisms, that restrict Alcama expression
to endoderm and dlx genes to NC, is needed to gain a more complete
understanding of the process of chondrogenesis.
Alcama interacts with Nadl1.1 on the NC to mediate differentiation
signals
We established that Nadl1.1, a known interacting partner of Alcama
expressed in NC, is important for cartilage morphogenesis and its
knockdown results in similar cartilage defects to alcama knockdown.
We also demonstrated that nadl1.1 is necessary for Alcama-mediated
rescue of NC differentiation in edn1−/− mutants and that Alcama and
Nadl1.1 interact during cartilage formation, either directly or indirectly.
Hence we concluded that Nadl1.1 possibly transmits Alcama-mediated
Edn1 signaling to the NC. Future studies will focus on how Nadl1.1
activates dlx genes in the NC.
One possible function for Alcama and Nadl1.1 interaction during NC
differentiation and cartilage morphogenesis may be to simply maintain
cell–cell contacts between the endoderm and NC. Support for this
hypothesis is provided by the integrinα5 mutant and the Eph-ephrin
system. Integrins are required for cell adhesion and migration in many
tissues (Benoit et al., 2009; Brakebusch and Fassler, 2005). The zebraﬁsh
integrinα5mutant has defects in formation of the ﬁrst pouch, resulting in
defective compaction and survival of NC cells adjacent to the ﬁrst pouch,
giving rise to a deformed hyoid cartilage (Crump et al., 2004). Eph genes
encode tyrosine kinase receptors for ephrin ligands. Eph-ephrinmediated
repulsion establishes polarity and boundaries during development
(Holder and Klein, 1999; Robinson et al., 1997). Since EphA3 is expressed
493P. Choudhry et al. / Developmental Biology 349 (2011) 483–493in ventral NC, it is also postulated that Eph-ephrin repulsion may play a
role in separating the dorsal and ventral cartilages, giving rise to the joint
between them(Kimmel et al., 2001).Hence, bothadhesive (integrins) and
repulsive forces (ephrins) play a role in NC differentiation. By analogy it is
conceivable that Alcama-Nadl1.1 mediated adhesion between the
endoderm and NC may play a similar role in chondrogenesis.
Conclusion
In summary, this is the ﬁrst demonstration that Alcama, a commonly
used marker for endoderm, plays a critical role in NC differentiation and
cartilage morphogenesis. We show that Edn1 regulates Alcama levels in
vivo and that Alcama functions downstream of Edn1 during cartilage
formation. In addition, we provide support for a mechanism by which
Alcama mediates Edn1-signaling by interacting with Nadl1.1 on NC cells.
Supplementary materials related to this article can be found online
at doi:10.1016/j.ydbio.2010.11.006.
Acknowledgments
The authors wish to thank Raju Kucherlapati and Len Zon for
material and technical support, Sarah Hutchinson for intellectual
contributions, and Gavin Wright (and his student) for technical
expertise. We wish to thank Chuck Kimmel for Alcian Blue-stained
furina−/− mutant zebraﬁsh, and Gage Crump for dlx plasmids. This
work was supported in part by R01 HD047863-01 and by the
Huntsman Cancer Foundation. Huntsman Cancer Institute core
facilities, supported by grant P30 CA042014, also facilitated this work.
References
Benoit, Y.D., Lussier, C., Ducharme, P.A., Sivret, S., Schnapp, L.M., Basora, N., Beaulieu, J.F.,
2009. Integrin alpha8beta1 regulates adhesion, migration and proliferation of human
intestinal crypt cells via a predominant RhoA/ROCK-dependentmechanism. Biol. Cell
101, 695–708.
Bowen, M.A., Aruffo, A.A., Bajorath, J., 2000. Cell surface receptors and their ligands: in
vitro analysis of CD6-CD166 interactions. Proteins 40, 420–428.
Brakebusch, C., Fassler, R., 2005. beta 1 integrin function in vivo: adhesion, migration
and more. Cancer Metastasis Rev. 24, 403–411.
Bretaud, S., Allen,C., Ingham,P.W., Bandmann,O., 2007. p53-dependentneuronal cell death in
a DJ-1-deﬁcient zebraﬁsh model of Parkinson's disease. J. Neurochem. 100, 1626–1635.
Burns, F.R., von Kannen, S., Guy, L., Raper, J.A., Kamholz, J., Chang, S., 1991. DM-GRASP, a
novel immunoglobulin superfamily axonal surface protein that supports neurite
extension. Neuron 7, 209–220.
Clouthier, D.E., Hosoda, K., Richardson, J.A., Williams, S.C., Yanagisawa, H., Kuwaki, T.,
Kumada, M., Hammer, R.E., Yanagisawa, M., 1998. Cranial and cardiac neural crest
defects in endothelin-A receptor-deﬁcient mice. Development 125, 813–824.
Clouthier, D.E., Williams, S.C., Yanagisawa, H., Wieduwilt, M., Richardson, J.A.,
Yanagisawa, M., 2000. Signaling pathways crucial for craniofacial development
revealed by endothelin-A receptor-deﬁcient mice. Dev. Biol. 217, 10–24.
Couly, G., Creuzet, S., Bennaceur, S., Vincent, C., Le Douarin, N.M., 2002. Interactions
between Hox-negative cephalic neural crest cells and the foregut endoderm in
patterning the facial skeleton in the vertebrate head. Development 129, 1061–1073.
Crump, J.G., Swartz, M.E., Kimmel, C.B., 2004. An integrin-dependent role of pouch
endoderm in hyoid cartilage development. PLoS Biol. 2, E244.
David, N.B., Saint-Etienne, L., Tsang, M., Schilling, T.F., Rosa, F.M., 2002. Requirement for
endoderm and FGF3 in ventral head skeleton formation. Development 129,
4457–4468.
DeBernardo, A.P., Chang, S., 1996. Heterophilic interactions of DM-GRASP: GRASP-
NgCAM interactions involved in neurite extension. J. Cell Biol. 133, 657–666.
Degen, W.G., van Kempen, L.C., Gijzen, E.G., van Groningen, J.J., van Kooyk, Y., Bloemers,
H.P., Swart, G.W., 1998. MEMD, a new cell adhesion molecule in metastasizing
human melanoma cell lines, is identical to ALCAM (activated leukocyte cell
adhesion molecule). Am. J. Pathol. 152, 805–813.
Depew, M.J., Lufkin, T., Rubenstein, J.L., 2002. Speciﬁcation of jaw subdivisions by Dlx
genes. Science 298, 381–385.
Dettlaff-Swiercz, D.A., Wettschureck, N., Moers, A., Huber, K., Offermanns, S., 2005.
Characteristic defects in neural crest cell-speciﬁc Galphaq/Galpha11- and Gal-
pha12/Galpha13-deﬁcient mice. Dev. Biol. 282, 174–182.
Diekmann, H., Stuermer, C.A., 2009. Zebraﬁsh neurolin-a and -b, orthologs of ALCAM,
are involved in retinal ganglion cell differentiation and retinal axon pathﬁnding. J.
Comp. Neurol. 513, 38–50.
Fashena, D., Westerﬁeld, M., 1999. Secondarymotoneuron axons localize DM-GRASP on
their fasciculated segments. J. Comp. Neurol. 406, 415–424.
Graham, A., 2003. Development of the pharyngeal arches. Am. J. Med. Genet. A 119A,
251–256.Heffron, D.S., Golden, J.A., 2000. DM-GRASP is necessary for nonradial cell migration
during chick diencephalic development. J. Neurosci. 20, 2287–2294.
Holder, N., Klein, R., 1999. Eph receptors and ephrins: effectors of morphogenesis.
Development 126, 2033–2044.
Ibanez, A., Sarrias, M.R., Farnos, M., Gimferrer, I., Serra-Pages, C., Vives, J., Lozano, F.,
2006. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte
surface receptor. J. Immunol. 177, 1152–1159.
Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., Schilling, T.F., 1995. Stages of
embryonic development of the zebraﬁsh. Dev. Dyn. 203, 253–310.
Kimmel, C.B., Miller, C.T., Kruze, G., Ullmann, B., BreMiller, R.A., Larison, K.D., Snyder, H.C.,
1998. The shaping of pharyngeal cartilages during early development of the zebraﬁsh.
Dev. Biol. 203, 245–263.
Kimmel, C.B., Miller, C.T., Moens, C.B., 2001. Speciﬁcation and morphogenesis of the
zebraﬁsh larval head skeleton. Dev. Biol. 233, 239–257.
Kopinke, D., Sasine, J., Swift, J., Stephens, W.Z., Piotrowski, T., 2006. Retinoic acid is
required for endodermal pouch morphogenesis and not for pharyngeal endoderm
speciﬁcation. Dev. Dyn. 235, 2695–2709.
Kurihara, Y., Kurihara, H., Suzuki, H., Kodama, T., Maemura, K., Nagai, R., Oda, H.,
Kuwaki, T., Cao, W.H., Kamada, N., et al., 1994. Elevated blood pressure and
craniofacial abnormalities in mice deﬁcient in endothelin-1. Nature 368, 703–710.
Lawson, N.D., Weinstein, B.M., 2002. In vivo imaging of embryonic vascular
development using transgenic zebraﬁsh. Dev. Biol. 248, 307–318.
Miller, C.T., Schilling, T.F., Lee, K., Parker, J., Kimmel, C.B., 2000. sucker encodes a
zebraﬁsh endothelin-1 required for ventral pharyngeal arch development.
Development 127, 3815–3828.
Miller, C.T., Yelon, D., Stainier, D.Y., Kimmel, C.B., 2003. Two endothelin 1 effectors,
hand2 and bapx1, pattern ventral pharyngeal cartilage and the jaw joint.
Development 130, 1353–1365.
Nair, S., Li, W., Cornell, R., Schilling, T.F., 2007. Requirements for endothelin type-A
receptors and endothelin-1 signaling in the facial ectoderm for the patterning of
skeletogenic neural crest cells in zebraﬁsh. Development 134, 335–345.
Neff, M.M., Neff, J.D., Chory, J., Pepper, A.E., 1998. dCAPS, a simple technique for the
genetic analysis of single nucleotide polymorphisms: experimental applications in
Arabidopsis thaliana genetics. Plant J. 14, 387–392.
Noden, D.M., 1983. The role of the neural crest in patterning of avian cranial skeletal,
connective, and muscle tissues. Dev. Biol. 96, 144–165.
Ofori-Acquah, S.F., King, J.A., 2008. Activated leukocyte cell adhesion molecule: a new
paradox in cancer. Transl. Res. 151, 122–128.
Parant, J.M., George, S.A., Holden, J.A., Yost, H.J., 2010. Genetic modeling of Li-Fraumeni
syndrome in zebraﬁsh. Dis. Model Mech. 3, 45–56.
Piotrowski, T., Nusslein-Volhard, C., 2000. The endoderm plays an important role in
patterning the segmented pharyngeal region in zebraﬁsh (Danio rerio). Dev. Biol.
225, 339–356.
Piotrowski, T., Schilling, T.F., Brand, M., Jiang, Y.J., Heisenberg, C.P., Beuchle, D., Grandel,
H., van Eeden, F.J., Furutani-Seiki, M., Granato, M., Haffter, P., Hammerschmidt, M.,
Kane, D.A., Kelsh, R.N., Mullins, M.C., Odenthal, J., Warga, R.M., Nusslein-Volhard, C.,
1996. Jaw and branchial arch mutants in zebraﬁsh II: anterior arches and cartilage
differentiation. Development 123, 345–356.
Robinson, V., Smith, A., Flenniken, A.M., Wilkinson, D.G., 1997. Roles of Eph receptors
and ephrins in neural crest pathﬁnding. Cell Tissue Res. 290, 265–274.
Robu, M.E., Larson, J.D., Nasevicius, A., Beiraghi, S., Brenner, C., Farber, S.A., Ekker, S.C.,
2007. p53 activation by knockdown technologies. PLoS Genet. 3, e78.
Rosano, L., Spinella, F., Di Castro, V., Nicotra, M.R., Dedhar, S., de Herreros, A.G., Natali, P.G.,
Bagnato, A., 2005. Endothelin-1 promotes epithelial-to-mesenchymal transition in
human ovarian cancer cells. Cancer Res. 65, 11649–11657.
Ruhin, B., Creuzet, S., Vincent, C., Benouaiche, L., Le Douarin, N.M., Couly, G., 2003.
Patterning of the hyoid cartilage depends upon signals arising from the ventral
foregut endoderm. Dev. Dyn. 228, 239–246.
Sato-Jin, K., Nishimura, E.K., Akasaka, E., Huber, W., Nakano, H., Miller, A., Du, J., Wu, M.,
Hanada, K., Sawamura, D., Fisher, D.E., Imokawa, G., 2008. Epistatic connections
between microphthalmia-associated transcription factor and endothelin signaling in
Waardenburg syndrome and other pigmentary disorders. FASEB J. 22, 1155–1168.
Thisse, B., Thisse, C., 2004. Fast release clones: a high throughput expression analysis.
ZFIN Direct Data Submission. (http://zﬁn.org).
Thisse, C., Thisse, B., 2005. High throughput expression analysis of ZF-models
consortium clones.
Walker, M.B., Miller, C.T., Cofﬁn Talbot, J., Stock, D.W., Kimmel, C.B., 2006. Zebraﬁsh
furin mutants reveal intricacies in regulating endothelin 1 signaling in craniofacial
patterning. Dev. Biol. 295, 194–205.
Walker, M.B., Miller, C.T., Swartz, M.E., Eberhart, J.K., Kimmel, C.B., 2007. phospholipase
C, beta 3 is required for endothelin 1 regulation of pharyngeal arch patterning in
zebraﬁsh. Dev. Biol. 304, 194–207.
Weiner, J.A., Koo, S.J., Nicolas, S., Fraboulet, S., Pfaff, S.L., Pourquie, O., Sanes, J.R., 2004. Axon
fasciculation defects and retinal dysplasias in mice lacking the immunoglobulin
superfamily adhesion molecule BEN/ALCAM/SC1. Mol. Cell. Neurosci. 27, 59–69.
Welten, M.C., de Haan, S.B., van den Boogert, N., Noordermeer, J.N., Lamers, G.E., Spaink, H.P.,
Meijer, A.H., Verbeek, F.J., 2006. ZebraFISH: ﬂuorescent in situ hybridization protocol and
three-dimensional imaging of gene expression patterns. Zebraﬁsh 3, 465–476.
Westerﬁeld, M., 2000. The zebraﬁsh book. A guide for the laboratory use of zebraﬁsh
(Danio rerio), 4th ed. University of Oregon Press, Eugene, Eugene, OR.
Wolman, M.A., Regnery, A.M., Becker, T., Becker, C.G., Halloran, M.C., 2007.
Semaphorin3D regulates axon axon interactions by modulating levels of L1 cell
adhesion molecule. J. Neurosci. 27, 9653–9663.
Zimmerman, A.W., Joosten, B., Torensma, R., Parnes, J.R., van Leeuwen, F.N., Figdor, C.G.,
2006. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation
induced by dendritic cells. Blood 107, 3212–3220.
